Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNKS | O95271 | 1/20 | 0.34 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | TDO2 | P48775 | 6/20 | 0.32 |
| ▸ | IDO1 | P14902 | 1/20 | 0.32 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.31 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.31 |
| ▸ | HTR2B | P41595 | 1/20 | 0.31 |
| ▸ | HTR5A | P47898 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | LIMK1 | P53667 | 2/20 | 0.30 |
| ▸ | BCHE | P06276 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17754685 | 0.95 | ALOX5 (0.43) | TNKSTNKS2ALOX5TDO2LIMK1 | |
| SCHEMBL26238249 | 0.94 | TNKS (0.37) | TNKSTNKS2ALOX5TDO2IDO1 | |
| SCHEMBL17754697 | 0.90 | ALOX5 (0.46) | TNKSTNKS2ALOX5TDO2IDO1 | |
| SCHEMBL17754701 | 0.89 | KDM4E (0.31) | — | |
| SCHEMBL17754693 | 0.88 | ALOX5 (0.43) | TNKSTNKS2ALOX5TDO2LIMK1 | |
| SCHEMBL17754688 | 0.88 | ALOX5 (0.47) | TNKSTNKS2ALOX5TDO2IDO1 | |
| SCHEMBL17754703 | 0.84 | KDM4E (0.33) | TNKSTNKS2ALOX5MAPT | |
| SCHEMBL17754637 | 0.83 | ALOX5 (0.51) | TNKSTNKS2ALOX5TDO2MAPT | |
| SCHEMBL14948266 | 0.83 | ALOX5 (0.51) | TNKSTNKS2ALOX5TDO2MAPT | |
| SCHEMBL17754702 | 0.83 | KDM4E (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11647669-B2 | Heterocyclic compound and organic light-emitting device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-05-09 | — | — | US | disclosed |
| US-9142788-B2 | Host materials for OLEDs | UNIVERSAL DISPLAY CORPORATION (US) | 2015-09-22 | — | — | US | disclosed |
| US-9142788-B2 | Host materials for OLEDs | UNIVERSAL DISPLAY CORPORATION (US) | 2015-09-22 | — | — | US | disclosed |
| US-8652656-B2 | Triphenylene silane hosts | UNIVERSAL DISPLAY CORPORATION (US) | 2014-02-18 | — | — | US | disclosed |
| US-8652656-B2 | Triphenylene silane hosts | UNIVERSAL DISPLAY CORPORATION (US) | 2014-02-18 | — | — | US | disclosed |
| US-20130119353-A1 | TRIPHENYLENE SILANE HOSTS | UNIVERSAL DISPLAY CORPORATION (US) | 2013-05-16 | — | — | US | disclosed |
| US-20130119353-A1 | TRIPHENYLENE SILANE HOSTS | UNIVERSAL DISPLAY CORPORATION (US) | 2013-05-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11647669-B2 | Heterocyclic compound and organic light-emitting device including the same | CRY1, CYP1A1, CRY2 | TNKS 2356/4885TNKS2 2972/4885ALOX5 1009/4885 |
| US-20130119353-A1 | TRIPHENYLENE SILANE HOSTS | OCIAD2, OCIAD1, YAP1 | TNKS 1795/4885TNKS2 1811/4885ALOX5 738/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.